Vanguard Portfolio Management
KMTS

Vanguard Portfolio Management’s Kestra Medical Technologies KMTS Stock Holding History

Vanguard Portfolio Management’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.5M Buy
255,329
+36,502
+17% +$764K ﹤0.01% 2360
2026
Q1 		$4.36M Buy
+218,827
New +$5.16M ﹤0.01% 2367

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Vanguard Portfolio Management's KMTS Position: Q2 2026 in Review

Vanguard Portfolio Management increased its Kestra Medical Technologies (KMTS) stake by 17% in Q2 2026, buying an estimated $764K and bringing the position to 255,329 shares worth $6.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2360.

Vanguard Portfolio Management first reported a position in KMTS in Q1 2026 and has held it in 2 quarters since. 108 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • Vanguard Portfolio Management held 255,329 shares of Kestra Medical Technologies worth $6.5M as of Q2 2026.
  • Vanguard Portfolio Management bought 36,502 Kestra Medical Technologies shares in Q2 2026, an estimated $764K.
  • Kestra Medical Technologies made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #2360 holding.
  • Vanguard Portfolio Management first reported a position in Kestra Medical Technologies in Q1 2026 and has held it in 2 quarters since.
  • 108 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.